Rainbow BioSciences, LLC: Tech Innovations Drive Big Growth in $60 Billion Drug Delivery Market
Published: Mar 13, 2013
NOKOMIS, Fla.--(BUSINESS WIRE)--The next generation of advanced pharmaceutical technologies could be poised to fuel remarkable growth in the $60 billion global drug delivery market, and Rainbow Biosciences—the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC)—plans to be right in the middle of the action. New drug delivery methods are seen by some pharmaceutical giants as a crucial growth generator, and new innovations are spreading across the healthcare sector. Many experts believe that personalized medicine is the future of healthcare, and customized drug delivery has the potential to drastically change the way value is assessed and compensated in the U.S. healthcare system.